Clinical Trials Logo

Filter by:
NCT ID: NCT00808743 Completed - Clinical trials for Familial Adenomatous Polyposis

Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis

PreDuoFAP
Start date: May 2009
Phase: Phase 2/Phase 3
Study type: Interventional

Duodenal carcinomas are the leading cause of mortality in patients with Familial Adenomatous Polyposis (FAP) who underwent prophylactic colorectal surgery. The purpose of this study is to determine wether celecoxib combined with ursodeoxycholic acid is an effective chemoprevention strategy to influence the progression of duodenal adenomas to carcinomas in patients with FAP.

NCT ID: NCT00808067 Completed - Atrial Fibrillation Clinical Trials

RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial

Start date: November 2008
Phase: Phase 3
Study type: Interventional

The purposes of this study are: 1. To evaluate the long-term safety of dabigatran etexilate 2. To assess the effect of a knowledge translation intervention on patient outcomes

NCT ID: NCT00807976 Completed - Clinical trials for Diabetes Mellitus Type 2

Orthostatic Hypotension and Diabetes Mellitus

ODET
Start date: January 2009
Phase: N/A
Study type: Observational

Rationale: Orthostatic hypotension increases with age and is associated with increased vascular and all-cause mortality. The prevalence of orthostatic hypotension is also increased in diabetic subjects. In order to prevent related adverse events and vascular mortality it is of great interest to examine the prevalence of orthostatic hypotension in elderly diabetic subjects. Objective: To examine the prevalence of orthostatic hypotension and associated adverse events in type 2 diabetic elderly subjects. Study design: Cross-sectional observational study. Study population: Elderly type 2 diabetic subjects (70 years and older).

NCT ID: NCT00807703 Completed - Parkinson Disease Clinical Trials

Select Stim: Selective Stimulation of the Subthalamic Nucleus in Parkinson's Disease. "A Feasibility Study"

Select Stim
Start date: September 2008
Phase: N/A
Study type: Interventional

In the advanced stages of Parkinson Disease deep brain stimulation of the subthalamic nucleus (STN DBS) is the next therapeutic option. Despite the beneficial motor effects there are important negative side-effects of STN DBS. Our hypothesis is that changes in cognition and behavior during STN DBS are related to stimulation of the non-motor parts of the STN. The primary objective is to avoid cognitive and affective side effects by selective stimulation of the STN motor part. The main objective of this feasibility study is to measure the patients burden and to test the technical feasibility. Intervention: The intervention is an expansion of the classical STN DBS procedure. The targeting using the multichannel registration system by stimulation of the motor cortex and registration of the subthalamic nucleus will be added to the procedure. For this procedure, it is necessary to place a subdural strip under the skull.

NCT ID: NCT00807508 Completed - Aging Clinical Trials

Leucine Supplementation in Elderly Men

Start date: January 2007
Phase: Phase 1/Phase 2
Study type: Interventional

In the present study the investigators aim to determine whether leucine supplementation can augment muscle mass and strength and improve body composition in healthy elderly men

NCT ID: NCT00806819 Completed - Clinical trials for Carcinoma, Non-Small-Cell Lung

Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC

Start date: December 2008
Phase: Phase 3
Study type: Interventional

The trial will be performed to evaluate if BIBF 1120 in combination with standard pemetrexed therapy is more effective than placebo (inactive capsule) plus standard pemetrexed therapy in patients with stage IIIB, IV or recurrent NSCLC. Safety information about BIBF1120/pemetrexed will be obtained.

NCT ID: NCT00806533 Completed - Surgery Clinical Trials

Non-Interventional (Observational) Post-Authorization Safety Study of HES 130/0.42 in Paediatric Patients

Start date: May 2006
Phase: N/A
Study type: Observational

This observational (non-interventional) post-authorization safety study (PASS) will investigate the application of Venofundin 6% and of Tetraspan 6% in children with special regard to drug safety.

NCT ID: NCT00806026 Completed - Clinical trials for Idiopathic Restless Legs Syndrome

Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients

RLS
Start date: December 2008
Phase: Phase 3
Study type: Interventional

This purpose of this study is to investigate the efficacy and tolerability of pregabalin in treating idiopathic RLS patients for up to 12 months.

NCT ID: NCT00805415 Completed - Clinical trials for Ovulation Inhibition

Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens

Start date: March 2003
Phase: Phase 2
Study type: Interventional

The aim of the study is to investigate the ovulation inhibition of two 4-phasic oral contraceptive regimens.

NCT ID: NCT00805168 Completed - Clinical trials for Pneumonia, Bacterial

Inhaled Amikacin Solution (BAY 41-6551) as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia

INHALE 2
Start date: May 28, 2013
Phase: Phase 3
Study type: Interventional

To demonstrate that as adjunctive therapy to intravenous (IV) antibiotics, BAY 41-6551 400 mg (amikacin as free base) administered as an aerosol by the Pulmonary Drug Delivery System (PDDS) Clinical every 12 hours is safe and more effective than placebo (aerosolized normal saline) administered as an aerosol by the PDDS Clinical every 12 hours, in intubated and mechanically-ventilated patients with Gram-negative Pneumonia. The secondary endpoint objectives are to evaluate the superiority of aerosolized BAY 41-6551 versus aerosolized placebo in pneumonia-related mortality, the Early Clinical Response at Day 10, the days on ventilation, and the days in the intensive care unit (ICU).